Search Results

Filter
  • 1-10 of  151,091 results for ""CLOZAPINE""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

A Systematic Review of Clozapine Concentration-Dose Ratio from Therapeutic Drug Monitoring Studies in Children and Adolescents Treated with Clozapine for Mental Disorders.

  • Authors : Jiménez-Fernández S; Child and Adolescent Mental Health Unit, Virgen de Las Nieves University Hospital, Granada, Spain.; CTS-549 Research Group (Psychiatry and Neurosciences), Junta de Andalucía, Spain.

Subjects: Clozapine*/Clozapine*/Clozapine*/therapeutic use ; Clozapine*/Clozapine*/Clozapine*/pharmacokinetics ; Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/therapeutic use

  • Source: Therapeutic drug monitoring [Ther Drug Monit] 2024 Apr 01; Vol. 46 (2), pp. 170-180. Date of Electronic Publication: 2023 Nov 16.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7909660 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

The cardiovascular toxicity of clozapine in embryonic zebrafish and RNA sequencing-based transcriptome analysis.

  • Authors : Ding Z; Department of Pathology, School of Basic Medicine, Anhui Medical University, Hefei, 230032, China.; Department of Forensic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.

Subjects: Zebrafish* ; Clozapine*/Clozapine*/Clozapine*/toxicity ; Clozapine*/Clozapine*/Clozapine*/metabolism

  • Source: Journal of applied toxicology : JAT [J Appl Toxicol] 2024 Feb; Vol. 44 (2), pp. 175-183. Date of Electronic Publication: 2023 Aug 22.Publisher: John Wiley And Sons Country of Publication: England NLM ID: 8109495 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

Restarting smoking after discharge from clozapine inpatient initiation: Elevated rehospitalization rates smoking & clozapine rehospitalization.

  • Authors : So R; Okayama Psychiatric Medical Center, Okayama, Japan.; Tsukahara M

Subjects: Clozapine*/Clozapine*/Clozapine*/adverse effects ; Antipsychotic Agents*; Humans

  • Source: Psychiatry and clinical neurosciences [Psychiatry Clin Neurosci] 2024 Apr; Vol. 78 (4), pp. 259-260. Date of Electronic Publication: 2024 Jan 31.Publisher: Blackwell Science Country of Publication: Australia NLM ID: 9513551 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

NMDA glutamate receptor antagonist MK-801 induces proteome changes in adult human brain slices which are partially counteracted by haloperidol and clozapine.

  • Authors : de Almeida V; Laboratory of Neuroproteomics, Department of Biochemistry and Tissue Biology, Institute of Biology, University of Campinas (UNICAMP), Campinas, Brazil.; Mendes ND

Subjects: Clozapine*/Clozapine*/Clozapine*/pharmacology ; Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/pharmacology; Animals

  • Source: Journal of neurochemistry [J Neurochem] 2024 Mar; Vol. 168 (3), pp. 238-250. Date of Electronic Publication: 2024 Feb 08.Publisher: Wiley on behalf of the International Society for Neurochemistry Country of Publication: England NLM ID: 2985190R Publication Model: Print-Electronic

Record details

×
Academic Journal

Overcoming Obstacles to Clozapine Treatment: A Case of Clozapine Rechallenge in ECT-Resistant Schizophrenia With Catatonic Features.

Subjects: Clozapine*/Clozapine*/Clozapine*/adverse effects ; Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy ; Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/adverse effects

  • Source: Journal of clinical psychopharmacology [J Clin Psychopharmacol] 2024 Mar-Apr 01; Vol. 44 (2), pp. 182-185.Publisher: Williams And Wilkins Country of Publication: United States NLM ID: 8109496 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Concomitant Use of Clozapine and Suvorexant Associated With Doubling of Clozapine Plasma Levels: A Case Report.

Subjects: Clozapine*/Clozapine*/Clozapine*/adverse effects ; Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/adverse effects; Humans

  • Source: Journal of clinical psychopharmacology [J Clin Psychopharmacol] 2024 Mar-Apr 01; Vol. 44 (2), pp. 185-187. Date of Electronic Publication: 2024 Jan 15.Publisher: Williams And Wilkins Country of Publication: United States NLM ID: 8109496 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Clozapine-N-oxide protects dopaminergic neurons against rotenone-induced neurotoxicity by preventing ferritinophagy-mediated ferroptosis.

  • Authors : Sun Q; National-Local Joint Engineering Research Center for Drug-Research and Development (R & D) of Neurodegenerative Diseases, Dalian Medical University, No. 9 W. Lvshun South Road, Dalian 116044, China; Department of Neurology, Dalian University Affiliated Xinhua Hospital, No. 156 W. Wansui Road, Dalian 116021, China.

Subjects: Clozapine*/Clozapine*/Clozapine*/pharmacology ; Clozapine*/Clozapine*/Clozapine*/metabolism ; Neuroprotective Agents*/Neuroprotective Agents*/Neuroprotective Agents*/pharmacology

  • Source: Free radical biology & medicine [Free Radic Biol Med] 2024 Feb 20; Vol. 212, pp. 384-402. Date of Electronic Publication: 2024 Jan 03.Publisher: Elsevier Science Country of Publication: United States NLM ID: 8709159 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Validation of Population Pharmacokinetic Models for Clozapine Dosage Prediction.

  • Authors : Berneri M; Schools of Medicine & Biomedical Sciences, University of Western Australia, Crawley, Western Australia, Australia.; Jha U

Subjects: Clozapine*/Clozapine*/Clozapine*/therapeutic use ; Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy ; Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/pharmacokinetics

  • Source: Therapeutic drug monitoring [Ther Drug Monit] 2024 Apr 01; Vol. 46 (2), pp. 217-226. Date of Electronic Publication: 2024 Feb 27.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7909660 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

A Short Turnaround of Clozapine Blood Level Results Within 6 hours is Essential for Effective Management of Severely Ill Persons with Treatment-Resistant Schizophrenia.

  • Authors : Vincent PD; Department of Pharmacy, Institut universitaire en santé mentale de Montréal, Montréal, Canada.; Faculty of Pharmacy, Université de Montréal, Montréal, Canada.

Subjects: Clozapine*/Clozapine*/Clozapine*/therapeutic use ; Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy ; Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/therapeutic use

  • Source: Therapeutic drug monitoring [Ther Drug Monit] 2024 Apr 01; Vol. 46 (2), pp. 274-275. Date of Electronic Publication: 2024 Feb 09.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7909660 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Novel Identification of Cysteinyl Derivatives of Toxic Clozapine Nitrenium Ions and the Effect of Valproic Acid on Metabolite Formation: A Study Using Reprocessed High-Resolution Mass Spectra of Analyzed Therapeutic Drug Monitoring Samples.

  • Authors : Wollmann BM; Center for Psychopharmacology, Diakonhjemmet Hospital, Oslo, Norway; and.

Subjects: Clozapine* ; Antipsychotic Agents*; Humans

  • Source: Therapeutic drug monitoring [Ther Drug Monit] 2024 Apr 01; Vol. 46 (2), pp. 265-269. Date of Electronic Publication: 2024 Jan 26.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7909660 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  151,091 results for ""CLOZAPINE""